403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Fennec Pharmaceuticals Inc.
(MENAFN- Baystreet) 09:50 AM EST - Fennec Pharmaceuticals Inc. : Announced that Norgine Pharmaceuticals Ltd., a leading European specialist Pharmaceutical company, has commercially launched PEDMARQSI (sodium thiosulfate injection) in Germany. Fennec Pharmaceuticals Inc.
shares T are trading unchanged at $9.49.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Manuka Honey Market Report 2024, Industry Growth, Size, Share, Top Compan...
- Modular Kitchen Market 2024, Industry Growth, Share, Size, Key Players An...
- Acrylamide Production Cost Analysis Report: A Comprehensive Assessment Of...
- Fish Sauce Market 2024, Industry Trends, Growth, Demand And Analysis Repo...
- Australia Foreign Exchange Market Size, Growth, Industry Demand And Forec...
- Cold Pressed Oil Market Trends 2024, Leading Companies Share, Size And Fo...
- Pasta Sauce Market 2024, Industry Growth, Share, Size, Key Players Analys...
Comments
No comment